Proposed Secondary Placing

RNS Number : 9027Z
abrdn PLC
27 January 2022
 

27 January 2022

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM THE UNITED STATES OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT IS NOT AN OFFER OF SECURITIES FOR SALE IN ANY JURISDICTION, INCLUDING THE UNITED STATES.

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION.

 

FOR IMMEDIATE RELEASE

 

abrdn plc ("abrdn" or the "Company")
Proposed Secondary Placing  in Phoenix Group Holdings plc

abrdn announces the proposed sale of approximately 40 million ordinary shares (the "Placing Shares") of its shareholding in Phoenix Group Holdings plc ("Phoenix"), representing approximately 4% of Phoenix's issued share capital, to institutional investors (the "Placing").

The Company reconfirms its commitment to its strategic partnership with, and retained shareholding in, Phoenix. With its strong capital resources, abrdn intends to return the net proceeds of the Placing to shareholders.

Stephen Bird, Chief Executive Officer of abrdn, commented:

"Our strategic partnership with Phoenix, the largest life and pensions consolidator in Europe, remains important for us, as evidenced by the simplified and extended relationship we announced in February 2021. Through our disciplined management of capital, I am pleased that we are well positioned to return the proceeds of this transaction to shareholders."

 

abrdn currently owns 144.1 million ordinary shares in Phoenix, representing approximately 14.4% of Phoenix's issued share capital. Following completion of the Placing, abrdn's holding will represent approximately 10.4% of Phoenix's issued share capital and abrdn will continue to appoint a director to Phoenix's Board.

The Company has a strong capital position with an indicative pro forma regulatory capital surplus (post IFPR) as at 30 September 2021 of c.£0.5 billion, including the impact of the interactive investor acquisition announced in December. In addition, abrdn has listed investments worth c.£2billion1, after adjusting for the Placing.

As such, abrdn intends to return the net proceeds of the Placing to shareholders, with the method and timing of the return to be announced as soon as practicable after the Company's results on 1 March.

The Company takes a disciplined approach to the management of its capital resources and will continue to invest in the business to accelerate its growth strategy and deliver long term value for shareholders.

The price per Placing Share will be determined by an accelerated book-building process to institutional investors facilitated by Goldman Sachs International ("Goldman Sachs"), to be launched immediately after release of this announcement. The book-building may be closed at any time and the results of the Placing will be announced as soon as practicable thereafter. The Placing is subject to demand, price and market conditions.

Goldman Sachs has been appointed by the Company as sole Global Coordinator and Bookrunner for the Placing. The Company has agreed not to sell or distribute any further shares from its proprietary shareholding in Phoenix for a period of 180 days after launch of the Placing (subject to customary carve outs, and waiver by Goldman Sachs).

A further announcement will be made following completion and pricing of the Placing.

Phoenix is not a party to the Placing and will not receive any proceeds from the Placing.

Enquiries:

abrdn plc

Catherine Nash

+44 (0)7798 518657

 

Goldman Sachs International

Charlie Lytle

Mark Maislish

Tom Hartley

George MacGregor

+44 (0) 207 774 1000

 

1 As at 26 January 2022

Important notices:

This announcement has been issued by and is the sole responsibility of the Company.

This announcement is for information purposes only and is not intended to and does not constitute an offer to sell, or the solicitation of an offer to subscribe for or buy, any shares nor any other securities in any jurisdiction. Shares will not be generally made available or marketed to the public in the  United Kingdom or any other jurisdiction in connection with the Placing.



 

 

Overseas jurisdictions

The distribution of this announcement into jurisdictions other than the United Kingdom may be restricted by law, and, therefore, persons into whose possession this announcement comes should inform themselves about and observe any such restrictions. Any failure to comply with any such restrictions may constitute a violation of the securities laws of such jurisdiction.

In particular, the securities referred to herein have not been and will not be registered under the United States Securities Act of 1933, as amended (the "Securities Act") and may not be offered, sold or transferred, directly or indirectly, in or into the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and in compliance with the applicable securities laws of any state or other jurisdiction of the United States. There will be no public offer of any securities in the United States.

Disclaimer

Goldman Sachs International, which is authorised by the Prudential Regulation Authority and regulated in the United Kingdom by the Financial Conduct Authority and the Prudential Regulation Authority, is acting for the Company in connection with the Placing and no-one else and they will not be responsible to anyone other than the Company for providing advice in relation to the Placing or any other matter referred to in this announcement.

This announcement does not constitute a recommendation to participate in the Placing. The price and value of securities and any income from them can go down as well as up. Past performance is not a guide to future performance. Acquiring shares may expose an investor to a significant risk of losing all of the amount invested. Potential investors should consult an independent financial advisor as to the suitability of the Placing for the entity or person concerned. The Company reserves the right not to proceed with the Placing or to vary the terms of the Placing in any way.

Forward-looking statements

This announcement includes statements that are, or may be deemed to be, forward-looking statements. These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "intends", "expects", "will", or "may", or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. These forward-looking statements include all matters that are not historical facts and include statements regarding intentions, beliefs or current expectations. No assurances can be given that the forward-looking statements in this announcement will be realised. As a result, no undue reliance should be placed on these forward-looking statements as a prediction of actual events or otherwise.

 

LEI number of abrdn plc: 0TMBS544NMO7GLCE7H90

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBLGDBRUDDGDR

Companies

Abrdn (ABDN)
UK 100

Latest directors dealings